Claire Catherinet, PhD, is a seasoned professional in life sciences venture capital, currently serving at Sofinnova Partners since 2021, following a previous role at Andera Partners from 2018 to 2020. With a foundational experience as a PhD student at Institut Curie from 2013 to 2017 and a research associate at The Heart Research Institute in 2011-2012, Claire's research focused on the anti-inflammatory properties of miRNAs in atherosclerosis. Academic credentials include a Doctor of Philosophy in Cell Biology, Oncology, and Hematology from Université Paris Cité, a Diplôme d'ingénieur from L'Institut Agro Rennes-Angers, and a degree in Biopharmaceutical Management from ESCP Business School.
This person is not in any teams
This person is not in any offices